EU automakers expect 25% output drop

Government handouts to car buyers has failed to halt the major slump.

By
July 15, 2009 09:16

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Car production in Europe is likely to drop by a quarter this year as government handouts to car buyers fail to halt a major slump, EU automakers said Tuesday. European car manufacturer association ACEA said "cash-for-clunkers" programs in thirteen European nations had helped lift sales of small cars but had failed to make a major dent in overall demand. Vehicle producers are reacting by cutting back, ACEA said. Van and truck production more than halved in the first quarter, it said, while car output fell 31 percent to 3.1 million; car sales fell a slower 17.2% in the same period. ACEA expects car output to fall 25% over the whole year and the production of trucks, vans and buses to decline at least 50% as companies don't replace older vehicles.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS